Cellular immune surveillance of central nervous system bypasses blood-brain barrier and blood-cerebrospinal-fluid barrier: Revealed with the New Marburg cerebrospinal-fluid model in healthy humans

Cytometry Part A

Volumn 87, Issue 3, 2015, Pages 227-243

  Kleine, Tilmann O ^a  

^a UNIVERSITY HOSPITAL MARBURG   (Germany)

Author keywords

B cells; Blood brain barrier; Blood CSF barrier; Blood venule barrier; Blood venule leptomeninges barrier; Cerebrospinal fluid (CSF); Flow cytometry immunophenotyping; Human lymphocytes; NK cells; Thoracic chyle lymphocytes

Indexed keywords

BIOLOGICAL MODEL; BLOOD BRAIN BARRIER; BRAIN; CELLULAR IMMUNITY; CEREBROSPINAL FLUID; CYTOLOGY; HUMAN; IMMUNOLOGY; LYMPHOCYTE SUBPOPULATION;

BLOOD-BRAIN BARRIER; BRAIN; CEREBROSPINAL FLUID; HUMANS; IMMUNITY, CELLULAR; LYMPHOCYTE SUBSETS; MODELS, NEUROLOGICAL;

EID: 84923225505     PISSN: 15524922     EISSN: 15524930     Source Type: Journal    
DOI: 10.1002/cyto.a.22589     Document Type: Article

References (245)

1. Ousman SS, Kubes P. Immune surveillance in the central nervous system. Nat Neurosci 2012;15:1096-1101.
2. Wekerle H, Linington C, Lassmann H, Meyermann R. Cellular immune reactivity within the CNS. Trends Neuro Sci 1986;9:271-277.
3. Casley-Smith JR, Sims MA. Protein concentrations in regions with fenestrated and continuous blood capillaries and in initial and collecting lymphatics. Microvasc Res 1976;12:245-257.
4. Farstad IN, Norstein J, Brandtzaeg P. Phenotyües of B and T cells in human intestinal and mesenteric lymph. Gastroenterology 1997;112:163-173.
5. Anderson AO, Shaw S. T cell adhesion to endothelium: The FRC conduit system and other anatomic and molecular features which facilitate the adhesion cascade in lymph node. Immunology 1993;5:271-282.
6. Rovenská E, Rovenský J. Lymphatic vessels: Structure and function. Israel Med Assoc J 2011;13:762-768.
7. Thalmann H. Zellveränderungen im Liquor cerebrospinalis nach pneumence-phalogramm und Myelogramm. Nervenarzt 1968;39:129-131.
8. Kleine TO, Weber L, Zöfel P. Changes with age in leukocyte counts, protein and IgG content of lumbar cerebrospinal fluid (CSF) of patients with inflammatory, ischemic, and hemorrhagic diseases or tumors of the central nervous system (CNS). Z Gerontol 1988;21:102-105.
9. Kleine TO. Nervensystem. In: Greiling H, Gressner AM, editors. Lehrbuch der Klinischen Chemie und Pathobiochemie. 2. Auflage. Stuttgart: Schattauer; 1989. pp 861-873.
10. Kleine TO, Hackler R, Lüttcke A, Zöfel P, Albrecht J, Rumpl E, et al. Laboratory diagnosis of radicular and pseudoradicular syndromes in cerebrospinal fluid (CSF): Reliability of methods in consideration of pathogenesic aspects. Eur J Clin Chem Biochem 1994;32:45-52.
11. Kleine TO. Liquor cerebrospinalis, liquor-protein, liquor-zellreaktionen, liquor-zellzählung, mikroskopisch. In: Gressner AM, Arndt T, editors. Lexikon der Medizinischen Laboratoriumsdiagnostik. 2. Auflage. Berlin: Springer-Verlag; 2013. pp 860-884.
12. Kleine TO, editor. Neue Labormethoden für die Liquordiagnostik. Stuttgart: Georg Thieme Verlag; 1980.
13. Guesdon JL, Ternynck T, Avrameas S. The use of avivin-biotin interaction in immunoenzymatic techniques. J Histochem Cytochem 1979;27:1131-1139.
14. Avrameas S. Indirect immunoenzyme techniques for the intracellular detection of antigens. Immunochemistry 1969;6:825-831.
15. Nakane PK, Pierce GB. Enzyme-labelled antibodies for the light and electron-microscopic localization of antigens. J Histochem Cytochem 1966;14:929-931.
16. Wicker R. Comparison of immunofluorescent and immunoenzymatic techniques applied to the study of viral antigens. Ann N Y Acad Sci 2006;177:490-500.
17. Ramos-Vara JA. Technical aspects of immunohistochemistry. Vet Pathol 2005;42:405-425.
18. Javois LC. Immunocytochemical methods and protocols. In: Javois LC, editor. Methods in Molecular Biology, 2nd ed. Totowa: Humana Press; 1999. pp 155-193.
19. Burnett R, Guichard Y, Barale E. Immunohistochemistry for light microscopy in safety evaluation of therapeutic agents: An overview. Toxicology 1997;119:83-93.
20. Ramos-Vara JA, Miller MA. When tissue antigens and antibodies get along: Revisiting the technical aspects of immunohistochemistry-the red, brown, and blue technique. Vet Pathol 2014;51:42-87.
21. Kleine TO. Liquor-Zellzählung, mikroskopisch, mechanisiert. In: Gressner AM, Arndt T, editors. Lexikon der Medizinischen Laboratoriumsdiagnostik. Band 1 Klinische Chemie. 1. Auflage. Heidelberg: Springer Verlag; 2007. pp 848-850.
22. Kleine TO. Zelldiagnostik des Liquor cerebrospinalis, ein Methodenvergleich. In: Kleine TO, editor. Neue Labormethoden für die Liquordiagnostik. Stuttgart: Georg Thieme Verlag; 1980. pp 76-92.
23. Wood JH. Physiology, pharmacology, and dynamics of cerebrospinal fluid. In: Wood JH, editor. Neurobiology of cerebrospinal fluid 1. New York: Plenum Press; 1980. pp 1-16.
24. Milhorat TH. Choroid plexus and cerebrospinal fluid production. Science 1969;166:1514-1516.
25. Pollay M, Curl F. Secretion of cerebrospinal fluid by the ventricular ependyma of the rabbit. Am J Physiol 1967;213:1031-1038.
26. Sahar A. Choroidal origin of cerebrospinal fluid. Isreal J Med Sci 1972;8:594-599.
27. Milhorat TH, Hammock MK, Fenstermacher JD, Rall DP, Levin VA. Cerebrospinal fluid production by the choroid plexus and brain. Science 1973;173:330-332.
28. Di Chiro G, Hammock MK, Bleyer WA. Spinal descent of hydrocephalus. Lancet 1967:1014-1017.
29. Di Chiro G, Larson SM, Harrington T, Johnston GS, Green MV, Swann SJ. Descent of cerebrospinal fluid to spinal subarachnoid space. Acta Radiol (Diagnosis) 1973;14:379-384.
30. DiChiro G, Hammock MK, Bleyer WA. Spinal descent of cerebrospinal fluid in man. Neurology (Minneapolis) 1976;26:1-8.
31. Milhorat TH, Hammock MK. Cerebrospinal fluid as reflection of internal milieu of brain. In: Wood JH, editor. Neurobiology of Cerebrospinal Fluid 2. New York: Plenum Press; 1983. pp 1-23.
32. Sweet WH, Locksley HB. Formation, flow, and reabsorption of cerebrospinal fluid in man. Proc Soc Exptl Biol Med 1953;84:397-402.
33. Cutler RWP, Page L, Galicich J, Watters GV. Formation and absorption of cerebrospinal fluid in man. Brain 1968;91:707-720.
34. Rubin RC, Henderson ES, Ommaya AK, Walker MD, Rall DP. The production of cerebrospinal fluid in man and its modification by acetazolamide. J Neurosurg 1966;25:430-436.
35. Davson H, Segal MB. Introduction. In: Davson H, Segal MB, editors. Physiology of the CSF and Blood-Brain Barriers. Boca Raton: CRP Press; 1996. pp 1-10.
36. Edsbagge M, Tisell M, Jacobsson L, Wikkelso C. Spinal cerebrospinal fluid absorption in healthy individuals. Am J Physiol Regul Integr Comp Physiol 2004;287:R1450-R1455.
37. Brodbelt A, Stoodley M. CSF pathways: A review. Br J Neurosurg 2007;21:510-520.
38. Davson H, Segal MB. The secretion of the cerebrospinal fluid. In: Davson H, Segal MB, editors. Physiology of the CSF and Blood-Brain Barriers. Boca Raton: CRP Press; 1996. pp 193-256.
39. Sato O, Bering EA. Extra-ventricular formation of cerebrospinal fluid. Brain Nerve 1967;19:883-885.
40. Bito LZ, Davson H. Local variations in cerebrospinal fluid composition and its relationship to the composition of the extracellular fluid of the cortex. Exp Neurol 1966;14:264-280.
41. Milhorat TH. Failure of choroid plexectomy as a treatment for hydrocephalus. Surg Gynecol Obstet 1974;139:505-508.
42. Milhorat TH, Hammock MK, Chien T, Davis DA. Normal rate of cerebrospinal fluid formation five years after bilateral choroid plexectomy. J Neurosurg 1976;44:735-739.
43. Lundervold A, Taxt T, Ersland L, Fenstad AM. Volume distribution of cerebrospinal fluid using multispectral MR imaging. Med Image Analysis 2000;4:123-136.
44. Bozanovic-Sosic R, Mollanji R, Johnston MG. Spinal and cranial contributions to total cerebrospinal fluid transport. AJP-Regulatory Integrative Comp Physiol 2001;281:R909-R916.
45. Bechter K. The peripheral cerebrospinal fluid outflow pathway-Physiology and pathophysiology of CSF recirculation: A review and hypothesis. Neurol Psychiatry Brain Res 2011;17:51-66.
46. Kido DK, Gomez DG, Pavese AM, Potts DG. Human spinal arachnoid villi and granulations. Neuroradiology 1976;11:221-228.
47. Pollay M. The function and strucuture of the cerebrospinal fluid out flow system. Cerebrospinal Fluid Res 2010;7:1-10.
48. Papaiconomou C, Bozanovic-Sosic R, Zakharov A, Johnston M. Does neonatal cerebrospinal fluid absorption occur via arachnoid projections or extracranial lymphatics? Am J Physiol Regul Integr Comp Physiol 2002;283:R869-R876.
49. Johnston M, Papaiconomou C. Cerebral fluid transport: A lymphatic perspective. News Physiol Sci 2002;17:227-230.
50. Koh L, Zakharov A, Johnston M. Integration of the subarachnoid space and lymphatics: Is it time to embrace a new concept of cerebrospinal fluid absorption? Cerebrospinal Fluid Res 2005;2:1-12.
51. Zakharov A, Papaiconomou C, Johnston M. Lymphatic vessels gain access to cerebrospinal fluid through unique association with olfactory nerves. Lymphatic Res Biol 2004;2:139-146.
52. Walter BA, Valera VA, Takahashi S, Ushiki T. The olfactory route for cerebrospinal fluid drainage intothroracic peripheral lymphatic system. Neuropathol Appl Neurobiol 2006;32:388-396.
53. Caversaccio M, Peschel O, Arnold W. The drainage of cerebrospinal fluid into the lymphatic system of the neck in humans. ORL J Otorhinolaryngol Relat Spec 1996;58:164-166.
54. Johnston M, Zakharov A, Papaiconomou C, Salmasi G. Evidence of connections between cerebrospinal fluid and nasal lymphytic vessels in humans, non-human primates and other mammalian species. Cerebrospinal Fluid Res 2004;1:1-13.
55. Schuenke M, Schulte E, Schumacher U, Ross LM, Lamperti ED, Voll M, et al. Thieme Atlas of Anatomy: Neck and Internal Organs. New York: Thieme; 2008. pp 136.
56. Nieuwenhuys R, Voogd J, van Huijzen C, Lange W. Das Zentralnervensystem des Menschen, 2nd ed. Berlin: Springer-Verlag; 1991. pp 54.
57. Perrin RN. Lymphatic drainage of the neuroaxis in chronic fatigue syndrome: A hypothetical model for the cranial rhythmic impulse. J Am Osteopath Ass 2007;107:218-224.
58. Enzmann DR, Pelc NJ. Normal flow patterns of intracranial and spinal cerebrospinal fluid defined with phase-contrast cine MR imaging. Radiology 1991;178:467-474.
59. Rapoport SI. Passage of proteins from blood to cerebrospinal fluid: Model for transfer by pores and vesicles. In: Wood JH, editor. Neurobiology of cerebrospinal fluid. New York: Plenum Press; 1983. pp 233-245.
60. Wilson EH, Weninger W, Hunter CA. Trafficking of immune cells in the central nervous system. J Clin Invest 2010;120:1368-1379.
61. Wolburg H, Paulus W. Choroid plexus: Biology and pathology. Acta Neuropath 20010;119:75-88.
62. Speake T, Whitwell C, Kajita H, Majid A, Brown PD. Mechanisms of CSF secretion by the choroid plexus. Microsci Res Tech 2001;52:49-59.
63. Brown PD, Davies SL, Speake T, Millar ID. Molecular mechanisms of cerebrospinal fluid production. Neuroscience 2004;129:957-970.
64. + T cells: Evidence for trafficking through choroid plexus and meninges via P-selectin. Proc Natl Acad Sci USA 2003;100:8389-8394.
65. Johanson C, Stopa E, McMillan P, Roth D, Funk J, Krinke G. The distributional nexus of choroid plexus to cerebrospinal fluid, ependyma and brain: Toxicologic/pathologic phenomena, periventricular destabilization, and lesion spread. Toxicol Pathol 2011;39:186-212.
66. Ballabh P, Braun A, Nedergaard M. The blood-brain barrier: An overview: Structure, regulation, and clinical implications. Neurobiol Dis 2004;16:1-13.
67. Serot JM, Foliguet B, Béné MC, Faure GH. Ultrastuctural and immunohistological evidence for dendritic-like cells within human choroid plexus epithelium. NeuroReport 1995;8:1995-1998.
68. Hanly A, Petito CK. HLA-DR-positive dendritic cells of the normal human choroid plexus: A potential reservoir of HIV in the central nervous system. Hum Pathol 1998;29:88-93.
69. Meeker RB, Williams K, Killebrew DA, Hudson LC. Cell trafficking through the choroid plexus. Cell Adhes Migration 2012;6:390-396.
70. Provencio JJ, Kivisäkk P, Tucky BH, Luciano MG, Ransohoff RM. Comparison of ventricular and lumbar cerebrospinal fluid T cells in non-inflammatory neurological disorder (NIND) patients. J Neuroimmunol 2005;163:179-184.
71. Hintzen RO, Fiszer U, Fredrikson S, Rep M, Polman CH, van Lier RAW, et al. Analysis of CD27 surface expression on T cell subsets in MS patients and control individuals. J Neuroimmunol 1995;56:99-105.
72. Ransohoff RM, Kivisäkk P, Kidd G. Three or more routes for leukocyte migration in the central nervous system. Nat Rev Immunol 2003;3:569-581.
73. Wolburg H, Noell S, Mack A, Wolburg-Buchholz K, Fallier-Becker P. Brain endothelila cells and the glio-vascular complex. Cell Tissue Res 2009;335:75-96.
74. Abbott NJ, Patabendige AAK, Dolman DEM, Yusof SR, Begley DJ. Structure and function of the blood-brain barrier. Neurobiol Dis 2010;37:13-25.
75. Dore-Duffy P, Cleary K. Morphology and properties of pericytes. Methods Mol Biol 2011;686:49-68.
76. Abbott NJ, Bundgaard M, Hughes CCW. Morphology of brain microvessels: A comparative approach. In: Hammersen F, Messmer H, editors. Cerebral Microcirculation. Prog Appl Microcirc Basel: Karger; 1989. pp 1-9.
77. Lawther BK, Kumar S, Krovvidi H. Blood-brain barrier. Crit Care Pain 2011;11:128-132.
78. Miller DW. Immunobiology of the blood-brain barrier. J Neuro Virol 1999;5:570-578.
79. Stammatovic SM, Keep RF, Andjelkovic AV. Brain endothelial cell-cell junctions: How to "open" the blood brain barrier. Curr Neuropharmacol 2008;6:179-192.
80. Nagy Z, Peters H, Hüttner I. Fracture faces of cell junctions in cerebral endothelium during normal and hyperosmotic conditions. Lab Invest 1984;50:313-322.
81. Piontek J, Winkler L, Wolburg H, Müller SL, Zuleger N, Piehl C, et al. Formation of tight junction: Determinants of homophilic interaction between classic claudins. FASEB J 2008;22:146-158.
82. Heiskala M, Peterson PA, Yang Y. The roles of claudin superfamily proteins in paracellular transport. Traffic 2001;2:93-98.
83. Bodenheimer TS, Brightman MW. A blood-brain barrier to peroxidise in capillaries surrounded by perivascular spaces. Am J Anat 1968;122:249-268.
84. Luissint AC, Artus C, Glacial F, Ganeshamoorthy K, Coutaud PO. Thight junctions at the blood brain barrier: Physiological architecture and disease-associated dysregulation. Fluids Barriers CNS 2012;9:1-12.
85. Reese TS, Karnovsky MJ. Fine structural localization of a blood-brain barrier to exogenous peroxidase. J Cell Biol 1967;34:207-217.
86. Liu W-Y, Wang Z-B, Zhang L-C, Wie X, Li L. Tight junction in blood-brain barrier: An overview of structure, regulation, and regulator substances. CNS Neurosci Therap 2012;18:609-615.
87. Tsukita S, Furuse M. Overcoming barriers in the study of tight junction functions: From occluding to claudin. Genes Cells 1998;3:569-573.
88. Cummins PM. Occludin: One protein, many forms. Mol Cell Biol 2012;32:242-250.
89. Hawkins BT, Davis TP. The blood-brain barrier/neurovascular unit in health and disease. Pharmacol Rev 2005;57:173-185.
90. Günzel D, Yu ASL. Claudins and the modulation of the tight junction permeability. Physiol Rev 2013;93:525-569.
91. Furuse M, Fujita K, Hiiragi T, Fujimoto K, Tsukita S. Claudin-1 and -2: Novel integral membrane proteins localizing at tight junctions with no sequence similarity to occluding. J Cell Biol 1998;141:1539-1550.
92. Tsukita S, Katsuno T, Yamazaki Y, Umeda K, Tamura A, Tsukita S. Roles of ZO-1 and ZO-2 in establishment of belt-like adherens and tight junctions with paracellular permselective barrier function. Ann N Y Acad Sci 2009;1165:44-52.
93. Chiba H, Osanai M, Murara M, Kojima T, Sawada N. Transmembrane proteins of tight junctions. Biochim Biophys Acta 2008;1778:588-600.
94. Findley MK, Koval M. Regulation and roles for claudin-family tight junction proteins. IUBMB Life 2009;61:431-437.
95. Itoh M, Nagafuchi A, Yonemura S, Kitani-Yasuda T, Tsukita SA, Tsukita SH. The 220-kDa protein colocalizing with cadherins in non-epithelial cells is identical to ZO-1, a tight junction-associated protein in epithelia cells:cDNA cloning and immunoelectron microscopy. J Cell Biol 1993;121:491-502.
96. Furuse M, Itoh M, Hirase T, Nagafuchi A, Yonemura S, Tsukita S. Direct association of occluding with ZO-1 and its possible involvement in the localization of occluding at tight junctions. J Cell Biol 1994;127:1617-1626.
97. Owens T, Bechmann I, Engelhardt B. Perivascular spaces and the two steps to neuroinflammation. J Neuropathol Exp Neurol 2008;67:1113-1121.
98. Wong D, Prameya R, Dorovini-Zis K. In vitro adhesion and migration of T lymphocytes across the monolayers of human brain microvessel endothelial cells: Regulation by ICAM-1, VCAM-1, E-selectin and PECAM-1. J Neuropath Exp Neurol 1999;58:138-152.
99. Barclay AN, Brown MH, Law SKA, McKnight AJ, Tomlinson MG, van der Merve PA. The Leucocyte Antigen FactsBook, 2nd ed. San Diego: Academic Press; 1997.
100. Butcher EC. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 1991;67:1033-1036.
101. Shimizu Y, Newman W, Tanaka Y, Shaw S. Lymphocyte interactions with endothelial cells. Immunol Today 1992;13:106-112.
102. Picker LJ, Butcher EC. Physiological and molecular mechanisms of lymphocyte homing. Ann Rev Immunol 1992;10:561-591.
103. Adams DH, Shaw S. Leucocyte-endothelial interactions and regulation of leucocyte migration. Lancet 1994;343:831-836.
104. Imhof BA, Dunon D. Leukocyte migration and adhesion. Adv Immunol 1995;58:345-416.
105. Ebnet K, Kaldjian EP, Anderson AO, Shaw S. Orchestrated information transfer underlying leukocyte endothelial interactions. Ann Rev Immunol 1996;14:155-177.
106. Salmi M, Jalkanen S. How do lymphocytes know where to go: current concepts and enigmas of lymphocyte homing. Adv Immunol 1997;64:139-218.
107. Kleine TO, Benes L. Immune surveillance of the human central nervous system (CNS): Different migration pathways of immune cells through the blood-brain barrier and blood-cerebrospinal fluid barrier in healthy persons. Cytometry A 2003;69A:147-151.
108. Callahan MK, Ransohoff RM. Analysis of leukocyte extravasation across the blood-brain barrier: Conceptual and technical aspects. Curr Allergy Asthma Rep 2004;4:65-73.
109. Bazzoni G. The JAM family of junctional adhesion molecules. Curr Opin Cell Biol 2003;15:525-530.
110. 2 integrin LFA-1 involved in transendothelial migration of leukocytes. Nat Immunol 2002;3:151-158.
111. Traweek ST, Kandalaft PL, Mehta P, Battifora H. The human hematopoietic progenitor cell antigen (CD34) in vascular neoplasia. Am J Clin Pathol 1991;96:25-31.
112. Martin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen 1 (LFA-1). Cell 1987;51:813-819.
113. Alon R, Kassner PD, Carr MW, Finger EB, Hemler ME, Springer TA. The integrin VLA-4 supports tethering and rolling in flow on VCAM-1. J Cell Biol 1995;128:1243-1253.
114. , an integrin that mediates rolling adhesion. J Cell Biol 2012, 196:131-146.
115. Casasnovas JM, Pieroni C, Springer TA. Lymphocyte function-associated antigen-1 binding residues in intercellular adhesion molecule-2 (ICAM-2) and the integrin binding surface in the ICAM subfamily. Proc Natl Acad Sci USA 1999;96:3017-3022.
116. Diamond MS, Staunton DE, de Fougerolles AR, Stacker SA, Garcia-Aguilar J, Hibbs ML, et al. ICAM-1 (CD54): A counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol 1990;111:3129-3139.
117. Adamson P, Etienne S, Couraud PO, Calder V, Greenwood J. Lymphocyte migration through brain endothelial cell monolayers involves signalling through endothelial ICAM-1 via a rho-dependent pathway. J Immunol 1999;162:2964-2973.
118. Svenningsson A, Hansson GK, Andersen O, Andersson R, Patarroyo M, Stemme S. Adhesion molecule expression of cerebrospinal fluid T lymphocytes: Evidence for common recruitment mechanisms in multiple sclerosis, aseptic meningitis, and normal controls. Ann Neurol 1993;34:155-161.
119. Lin SJ, Yan DC. ICAM-1 (CD54) expression on T lymphocytes and natural killer cells from umbilical cord blood: Regulation with interleukin-2 and interleukin-15. Cytokines Cell Mol Therap 2000;6:161-164.
120. Long EO. ICAM-1: Getting a grip on leukocyte adhesion. J Immunol 2011:186:5021-5023.
121. Seabrook TJ, Johnston M, Hay JB. Cerebral spinal fluid lymphocytes are part of the normal recirculating lymphocyte pool. J Neuroimmunol 1998;91:100-107.
122. Huang MT, Larbi KY, Scheiermann C, Woodfin A, Gerwun N, Haskard DO, et al. ICAM-2 mediates neutrophil transmigration in vivo: Evidence for stiumulus specificity and a role in PECAM-1-independent transmigration. Blood 2006;107:4721-4727.
123. Vestweber D. ICAM-2 and PECAM-1: 2 ateps in leukocyte transmigration. Blood 2006;107:4579-4580.
124. Muller WA, Weigl SA, Deng X, Phillips DM. PECAM-1 is required for transendothelial migration of leukocytes. J Exp Med 1993;178:449-460.
125. Naik UP, Eckfeld K. Junction adhesion molecule 1 (JAM-1). J Biol Regul Homeost Agents 2003;17:341-347.
126. Ley K, Laudanna C, Cybulsky MI, Nourshargh S. Getting to the site of inflammation: The leukocyte adhesion cascade updated. Nat Rev Immunol 2007;7:678-689.
127. Davson H, Segal MB. The blood-brain barrier. In: Davson H, Segal MB. Physiology of the CSF and Blood-Brain Barriers. Boca Raton: CRP Press; 1996. pp 49-91.
128. Lobb RR, Hemler ME. The pathophysiologic role of α4 integrins in vivo. J Clin Invest 1994;94:1722-1728.
129. Browing BG, Tizard R, Haskard DO, Benjamin CD, Dougas I, Kirchhausen T. Arrangement of domains, amino acid residues required for binding of vascular cell adhesion molecule-1 to its counter-receptor VLA-4 (alpha 4 beta 1). J Cell Biol 1994;124:601-608.
130. Vonderheide RH, Tedder TF, Springer TA, Staunton DE. Residues within a conserved amino acid motif of domains 1 and 4 of VCAM-1 are required for binding to VLA-4. J Cell Biol 1994;125:215-222.
131. Wawryk SO, Novotny JR, Wicks IP, Wilkinson D, Maher D, Salvaris E, et al. The role of the LAF-1/ICAM-1 interaction in human leukocyte homing and adhesion. Immunol Rev 1989;108;135-161.
132. van Wetering S, van den Berk N, van Buul JD, Mul FPJ, Lommerse I, Mous R, et al. VCAM-1-mediated Rac signalling controls endothelial cell-cell contacts and leukocyte transmigration. Am J Physiol Cell Physiol 2003;285:C343-C352.
133. Ilan N, Madri JA. PECAM-1: Old friend, new partners. Curr Opin Cell Biol 2003;15:515-524.
134. Piccio L, Rossi B, Scarpini E, Laudanna C, Giagulli C, Issekutz AC, et al. Molecular mechanisms involved in lymphocyte recruitment in inflamed brain microvessels: Critical roles for P selectin glycoprotein ligand-1 and heterotrimeric G(i)-linked receptors. J Immunol 2002;168:1940-1949.
135. Svenningsson A, Andersen O, Edsbagge M, Stemme S. Lymphocyte phenotype and subset distribution in normal cerebrospinal fluid. J Neuroimmunol 1995;63:39-46.
136. Neumann H, Mcdana IM, Bauer J, Lassmann H. Cytotoxic T lymphocytes in autimmune and degenerative CNS disease. Trends Neurosci 2002;25:313-319.
137. Aurrand-Lions M, Johnson-Leger C, Lamagna C, Ozaki H, Kita T, Imhof BA. Junctional adhesion molecules and interendothelial junctions. Cells Tissues Organs 2002;172:152-160.
138. Vorbrodt AW, Dobrogowska DH. Molecular anatomy of interendothelial junctions in human blood-brain microvessels. Folia Histochem Cytobiol 2004;42:67-75.
139. Anderson JM, Balda MS, Fanning AS. The structure and regulation of tight junctions. Curr Opin Cell Biol 1993;5:772-778.
140. Anderson JM, van Itallie CM. Tight junctions and the molecular basis for regulation of paracellular permeability. Gastrointest Liver Physiol 1995;32:G467-G475.
141. Brown RC, Davis TP. Calcium modulation of adherens and tight junction function: A potential mechanism for blood-brain barrier disruption after stroke. Stroke 2002;33:1706-1711.
142. Voisin MB, Pröbstl D, Nourshrgh S. Venular basement membranes ubiquitously express matrix protein low-expression regions. Am J Pathol 2010;176:482-495.
143. Davson H, Segal MB. Morphological aspects of the barriers. In: Davson H, Segal MB, editors. Physiology of the CSF and Blood-Brain Barriers. Boca Raton: CRP Press; 1996. pp 93-192.
144. Girard JP, Springer TA. High endothelial venules (HEVs) specialized endothelium for lymphocyte migration. Immunol Today 1995;16:449-457.
145. Rascher G, Wolburg H. The tight junctions of the leptomenigeal blood cerebrospinal fluid barrier during development. J Brain Res (J für Hirnforschung) 1997;38:525-540.
146. Hasegawa M, Yamashima T, Kida S, Yamashita J. Membranous ultrastructure of human arachnoid cells. J Neuropathol Exp Neurol 1997;56:1217-1227.
147. Alcolado R, Weller RO, Parrish EP, Garrod D. The cranial arachnoid and pia mater in man: Anatomical and ultrastructural observations. Neuropathol Appl Neurobiol 1988;14:1-17.
148. Lopes CAS, Mair WGP. Ultrastructure of the outer cortex and pia mater in man. Acta Neuropath 1974;28:79-86.
149. Ramsey HJ. Fine structure of the surface of the cerebral cortex of human brain. J Cell Biol 1965;26:323-333.
150. Jiménez AJ, Dominguez-Pinos MD, Guerra MM, Llebrez PF, Pérez-Figares JM. Structure and function of the ependymal barrier and diseases associated with ependyma disruption. Tissue Barriers 2014;2:1-13.
151. Siegel GJ, Agranoff BW, Albers RW, Fisher SK. Basic Neurochemistry: Molecular, Cellular and Medical Aspects, 6th ed. Piladelphia: Lippincott-Raven; 1999.
152. Cardoso FL, Brites D, Brito MA. Looking at the blood-brain barrier: Molecular anatomy and possible investigation approaches. Brain Res Rev 2010;64:328-363.
153. Saunders NR, Ek CJ, Habgood MD, Dziegielewska KM. Barriers in the brain: A renaissance? Trends Neurosci 2008;31:279-286.
154. Fisher M. Pericyte signaling in the neurovascular unit associated with capillary endothelial cells. Stroke 2009;40:S13-S15.
155. Abbott JN, Rönnbäck L, Hansson E. Astrocyte-endothelial interactions at the blood-brain barrier. Nat Rev Neurosci 2006;7:41-53.
156. Prat A, Biernacki K, Wosik K, Antel JP. Glial cell influence on the human blood-brain barrier. Glia 2001;36:145-155.
157. Balabanov R, Dore-Duffy O. Role of the CNS microvascular pericyte in the blood-brain barrier. J Neurosci Res 1998;53:637-644.
158. Muller WA. Leukocyte-endothelial-cell interactions in leukocyte transmigration and the inflammatory response. Trends Immunol 2003;24:326-333.
159. Hickey WF, Hsu BL, Kimura H. T-lymphocyte entry into the central nervous system. J Neurosci Res 1991;28:254-260.
160. Hickey WF. Leukocyte traffic in the central nervous system: participants and their roles. Semin Immunol 1999;11:125-137.
161. Hickey W. Basic principles of immunological surveillance of the normal central nervous system. Glia 2001;36:118-124.
162. Rea IM, McNerlan SE, Alexander HD. CD69, CD25, and HLA-DR activation antigen expression on CD3+ lymphocytes and relationship to serum TNF-alpha, IFN-gamma, and sIL-2R levels in aging. Exp Gerontol 1999;34:79-93.
163. Afeltra A, Galeazzi M, Sebastiani GD, Ferri GM, Caccavo D, Addessi MA, et al. Coexpression of CD69 and HLADR activation markers on synovial fluid T lymphocytes of patients affected by rheumatoid arthritis: A three-colour cytometric analysis. Int J Exp Pathol 1997;78:331-336.
164. Engelhardt B, Ransohoff RM. The ins and outs of T-lymphocyte trafficking to the CNS: Anatomical sites and molecular mechanisms. Trends Immunol 2005;26:485-495.
165. Davson H, Segal MB. The return of the CSF to the blood: The drainage mechanism. In: Davson H, Segal MB, editors. Physiology of the CSF and Blood-Brain Barriers. Boca Raton: CRP Press; 1996. pp 489-523.
166. Cicciarelli JC, Terasaki PI, Iwaki Y, Billing R, Yamaguchi T, Takahashi H, et al. DR-bearing T lymphocytes in thoracic duct lymph. Clin Immunol Immunopathol 1981;18:32-38.
167. Cicciarelli JC, Iwaki Y, Terasaki PI, Shirahama GS, Billing R, Hermes M, et al. Preliminary evidence of dual-marked lymphocytes in thoracic duct lymph fluid. Transplant Proc 1980;12:490-492.
168. Sweet WH, Brownell GL, Scholl JA, Bowsher DR, Benda PH, Stickley EE. The formation, flow and absorption of cerebrospinal fluid: Newer concepts based on studies with isotopes. Res Publ Assoc Nerv Ment Dis 1954;34:101-159.
169. Dereymaeker A, Stevens A, Rombouts JJ, Lacheron JM, Pierquin A. Study of the influence of the arterial pressure upon the morphology of cisternal CSF pulsation. Europ Neurol 1971;5:107-114.
170. Schroth G, Klose U. Cerebrospinal fluid flow. II. Physiology of respiration-related pulsations. Neuroradiology 1992;35:1-9.
171. Laitinen L. Origin of arterial pulsation of cerebrospinal fluid. Acta Neurol Scand 1968;44:168-176.
172. Du Boulay GH. Pulsatile movements in the CSF patways. Br J Radiol 1966;39:225-262.
173. Du Boulay GH, O'Connell J, Currie J, Bostick T, Verity P. Further investigations on pulsatile movements in the cerebrospinal fluid pathways. Acta Radiol (Stockholm) 1972;13:496-523.
174. Williams B. Cerebrospinal fluid pressue changes in response to coughing. Brain 1976;99:331-346.
175. Bering EA Jr. Choroid plexus and arterial pulsyation of cerebrospinal fluid. Demonstration of the choroid plexuses as a cerebrospinal fluid pump. AMA Arch NeurPsych 1955;73:165-172.
176. Friese S, Hamhaber U, Erb M, Klose U. B-waves in cerebral and spinal cerebrospinal fluid pulsation measurement by magnetic resonance imaging. J Comput Assist Tomogr 2004;28:255-262.
177. Dereymaeker A, Stevens A, Rombouts JJ, Lacheron JM, Pierquin A. Study on the influence of arterial pressure upon the morphology of cisternal CSF pulsations. Europ Neurol 1971;5:115-129.
178. Dunbar HS, Guthrie TC, Karpell B. A study of the cerebrospinal fluid pulse wave. Arch Neurol 1966;14:624-630.
179. Adolph RJ, Fukusumi H, Fowler NO. Origin of cerebrospinal fluid pulsations. Am J Physiol 1967;212:840-846.
180. Passing H, Bablok W. A new biometrical procedure for testing the equality of measurements from two different analytical methods. Application of linear regression procedures for method comparison studies in clinical chemistry, part I. J Clin Chem Clin Biochem 1983;21:709-720.
181. Brandsma D, Ulfman L, Reijneveld JC, Bracke M, Taphoorn MJB, Zwaginga JJ, et al. Constitutive integrin activation on tumor cells contributes to progression of leptomeningeal metastases. Neuro-Oncol 2006;8:127-136.
182. Kuttner BJ, Woodruff JJ. Selective adherence of lymphocytes to myelinated areas of rat brain. J Immunol 1979;122:1666-1671.
183. Dore-Duffy P, Goertz V, Rothman BL. Lymphocyte adherence to myelinated tissue in multiple sclerosis. J Clin Invest 1980;66:843-846.
184. Vigh B, Manzano e Silva MJ, David FC, Czirok SJ, Vincze C, Racz G, et al. The circumventricular organs of the brain: Do they represent a cerebrospinal fluid-dependent regulatory system? Med Hypotheses Res 2004;1:77-100.
185. Ganong WF. Circumventricular organs: Definition and role in the regulation of endocrine and autonomic function. Clin Exp Pharmacol Physiol 2000;27:422-427.
186. Sanin V, Heeß C, Kretzschmar HA, Schüller U. Recruitment of neural precursor cells from circumcentricular organs of patients with cerebral ischaemia. Neoropathol Appl Neurobiol 2013;39:510-518.
187. Brizzee KR, Klara PM. The structure of the mammalian area postrema. Fed Proc 1984;43:2944-2948.
188. Faraci FM, Choi J, Baumbach GL. Microcirculation of the area postrema. Permeability and vascular responses. Circ Res 1989;65:417-425.
189. Gross PM. Morphology and physiology of capillary systems in subregions of the subfornical organ and area postrrema. Can J Physiol Pharmacol 1991;69:1010-1025.
190. Price CJ, Hoyda TD, Ferguson AV. The area postrema: A brain monitor and integrator of systemic autonomic state. Neuroscientist 2008;14:182-194.
191. Loeffler C, Dietz K, Schleich A, Schlaszus H, Stoll M, Meyermann R, et al. Immune surveillance of the normal CNS take place in dependence of the locoregional blood-brain barrier configuaration and is mainly performed by CD3+/CD8+ lymphocytes. Neuropathology 2011;31:230-238.
192. von Andrian UH, Mackay CR. T-cell function and migration: Two sides of the same coin. N Engl J Med 2000;343:1020-1034.
193. Kristenson A. The variations in size (the lymphocyte profile) of the lymphocytes circulating in the blood in some normal and pathological conditions. Acta Med Scand 1949;133:157-161.
194. Schmid-Schonbein GW, Shin YY, Chien S. Morphometry of human leukocytes. Blood 1980;56:866-875.
195. Segel GB, Cokelet GR, Lichtman MA. The measurement of lymphocyte volume: Importance of reference particle deformability and counting solution tonicity. Blood 1981;57:894-899.
196. Friedl P, Weigelin B. Interstitial leukocyte migration and immune function. Nat Immunol 2008;9:960-969.
197. Wolf K, Müller R, Borgmann S, Bröcker EB, Friedl P. Amoeboid shape change and contact guidance: T-lymphocyte crawling through fibrillar collagen is independent of matrix remodeling by MMPs and other proteases. Blood 2002;102:3262-3269.
198. Inoue S, Leblond CP. Three-dimensional network of cords: The main component of basement membranes. Am J Anat 1988;181:341-358.
199. Leblond CP, Inoue S. Structure, composition, and assembly of basement membrane. Am J Anat 1989;185:367-390.
200. Inoue S. Basic structure of basement membranes is a fine network of "cords, " irregular anastomosing strands. Microsci Rews Tech 1994;1;28:29-47.
201. Gauthier J, Harel P. Human leukocytes: Their size distribution and mean corpuscular volume. Canad Med Ass J 1967;97:793-796.
202. Kleine TO. Liquor-differentialzellbild. In: Gressner AM, Arndt T, editors. Lexikon der Medizinischen Laboratoriumsdiagnostik. Band 1 Klinische Chemie. 1. Auflage. Heidelberg: Springer; 2007. pp 794-796.
203. Ischimura T, Hashimoto PH. Fine structure of basement membranes of the capillary endothelium and perivascular astrocyte in some circumventricular organs by three-dimensional SEM. J Ultrastruc Res 1984;86:220-227.
204. Del Bigio MR. The ependyma: A protective barrier between brain and cerebrospinal fluid. Glia 1995;14:1-13.
205. Hetzel W. Post-mortem modifications of the ependyma of the lateral ventricular wall. Acta Neuropathol 1980;51:15-22.
206. Coates PW. Supraependymal cells in recesses of the monkey third ventricle. Am J Anat 1973;136:533-539.
207. Coates PW. Supraependymal cells: Light and transmission electron microscopy extends scanning electron microscopic demonstration. Brain Res 1973;57:502-507.
208. Allen DJ, Low FN. The ependymal surface of the lateral ventricle of the dog as revealed by scanning electron microscopy. Am J Anat 1973;137:483-489.
209. Benschop RJ, Schedlowski M, Wienecke H, Jacobs R, Schmidt RE. Adrenergic control of natural killer cell circulation and adhesion. Brain Behav Immun 1997;11:321-332.
210. Virtanen I, Ylänne J, Vartio T, Saksela E. Huamn natural killer cells express different integrins and spread on fibronectin. Scand J Immunol 1991;33:421-428.
211. Gismondi A, Bisogno L, Mainiero F, Palmieri G, Piccoli M, Frati L, et al. Proline-rich tyrosine kinase-2 activation by ß1 integrin fibronectin receptor cross-linking and association with paxillin in human natural killer cells. J Immunol 1997;159:4729-4736.
212. Segat D, Pucillo C, Marotta G, Perris R, Colombatti SA. Differential attachment of human neoplastic B cells to purified extracellular matrix molecules. Blood 1994;83:1586-1594.
213. van de Wiel-van Kemenade E, van Kooyk Y, de Boer AJ, Huijbens RJF, Weder P, van de Kasteele W, et al. Adhesion of T and B lymphocytes to extracellular matrix and endothelial cells can be regulated through the ß subunit of VLA. J Cell Biol 1990;110:2157-2165.
214. Steffen BJ, Breier G, Butcher EC, Schulz M, Engelhardt B. ICAM-1, VCAM-1, and MAdCAM-1 are expressed on choroid plexus epithelium but not endothelium and mediate binding of lymphocytes in vitro. Am J Pathol 1996;148:1819-1838.
215. Kleine TO, Albrecht J, Zöfel P. Flow cytometry of cerebrospinal fluid (CSF) lymphocytes: Alterations of blood/CSF ratios of lymphocyte subsets in inflammation disorders of human central nervous system (CNS). Clin Chem Lab Med 1999;37:231-241.
216. Müller HAG, Toellner KM, Hiendlmayer G. Durchflußzytometrische Analytik von Liquor cerebrospinalis. Labmed 1991;15:69-72.
217. + T cells dominate the normal cerebrospinal fluid. Cytometry B 2011;80B:43-50.
218. Kleine TO, Hackler R, Mix E, Albrecht J, Kaiser C, Müller HAG. Analyse von Lymphozyten-Subpopulationen im Liquor cerebrospinalis. In: Schmitz G, Rothe G, Hrsg. Durchflußzytometrie in der klinischen Zelldiagnostik. Stuttgart: FK Schattauer; 1994. pp 189-197.
219. Kleine TO, Hildmann J, Albrecht J, Bien S. Liquordiagnostik: Analyse von Lymphozyten- und Monozyten-Subpopulationen im Liquor cerebrospinalis. In. Sack U, Tárnok A, Rothe G Hrsg. Zelluläre Diagnostik. Grundlagen, Methoden und klinische Anwendugen der Durchflusszytrometrie. Basel: Karger; 2007. pp 902-923.
220. Fredrikson S, Emerudh J, Olsson T, Forsberg P, Link H. Mononuclear cell types in cerebrospinal fluid and blood of patients with multiple sclerosis. Arch Neurol 1989;46:372-375.
221. Kleine TO, Albrecht J. Vereinfachte Durchflußzytometrie von Liquorzellen mit FACScan. Lab Med 1991;15:73-78.
222. Oreja-Guevara C, Sindern E, Raulf-Heimsoth M, Malin JP. Analysis of lymphocyte subpopulations in cerebrospinal fluid and peripheral blood in patients with multiple sclerosis and inflammatory diseases of the nervous system. Acta Neurol Scand 1998;98:310-313.
223. Antel JP, Peeples DM, Reder AT, Arnason BGW. Analysis of T regulator cell surface markers and functional properties in multiple sclerosis. J Neuroimmunol 1984;6:93-103.
224. Vrethem M, Dahle C, Ekerfelt C, Forsberg P, Danielsson O, Ernerudh J. CD4 and CD8 lymphocyte subsets in cerebrospinal fluid and peripheral blood from patients with multiple sclerosis, meningitis and normal controls. Acta Neurol Scand 1998;97:215-220.
225. Valentine VG, Raffin TA. The management of chylothorax. Chest 1992;102:586-591.
226. Edgren J, Weber TH. Radiation sensitivity of lymphocytes from human blood and from the thoracic duct. Acta Radiol Ther Phys Biol 1976;15:177-182.
227. Lemaire LCJM, van Deventer SJH, van Lanschot JJB, Meenan J, Gouma DJ. Phenotypical characterization of cells in the thoracic duct of patients with and without systemic inflammatory response syndrome and multiple organ failure. Scand J Immunol 1998;47:69-75.
228. Cameron JR, Skofronick JG, Grant RM. Physics of the Body, 2nd ed. Madison, WI: Medical Physics Publishing; 1999. pp 182.
229. Lucivero G, Pierucci G, Bono L. Lymphocyte subsets in peripheral blood and pleural fluid. Eur Respir J 1988;1:337-340.
230. Maeder M, Fontanel D, El-Hag K, Traichel B, Borovicka J. Chylothorax bei Leberzirrose. Schweiz Med Forum 2004;4:808-810.
231. Diaz-Guzman E, Culver DA, Stoller JK. Transudative chylothorax: Report of two cases and review of the literature. Lung 2005;183:169-175.
232. Ross JK. A review of the surgery of the thoracic duct. Thorax 19961;16:12-21.
233. Pettersson T, Klockars M, Hellström PE, Riska H, Wangel A. T and B lymphocytes in pleural effusions. Chest 1978;73:49-51.
234. Jeminez CA, Mhatre AD, Martinez CH, Eapen GA, Onn A, Morice RC. Use of an indwelling pleural catheter for the management of recurrent chylothorax in patients with cancer. Chest 2007;132:1584-1590.
235. Bessone LN, Ferguson TB, Burford TH. Chylothorax. Ann Thorac Surg 1971;12:527-550.
236. Merrigan BA, Winter DC, O'Sullivan GC. Chylothorax. Br J Surg 1997;84:15-20.
237. Tilney NL, Murray JE. The thoracic duct fistula as an adjunct to immunosuppression in human renal transplantation. Transplantation 1967;5:1204-1208.
238. Moisan T, Chandrasekhard AJ, Robinson J, Mckenna J, Marti G. Distribution of lymphocyte subpopulations in patients with exudative pleural effusions. Am Rev Respir Dis 1978;117:507-511.
239. Breaux JR, Marks C. Chylothorax causing reversible T-cell depletion. J Trauma 1988;28:705-707.
240. Gosh AK, Spriggs AI, Mason DY. Immunocytochemical staining of T and B lymphocytes in serous effusions. J Clin Pathol 1985;38:608-612.
241. Kochman S, Bernard J, Lavaud F, Cazabat A, Dubois de Montreynaud JM. T-lymphocyte subsets in pleural fluids: Discrimination according to traditional and monoclonal antibody-defined markers. Eur J Rispir Dis 1984;65:586-591.
242. Siemkowicz E, Diemer NH. Cytology of human cerebro-spinal fluid after cardiac arrest. Acta Neurol Scand 1978;57:1-7.
243. Wikkelso C, Blomstrand C. Cerebrospinal fluid proteins and cells in normal-pressure hydrocephalus. J Neurol 1982;228:171-180.
244. Summer K, Traugott U. Liquoreosinophilie nach Myelographie. J Neurol 1975;210:127-134.
245. Kleine TO, Warat JP. Blood/cerebrospinal fluid barrier to lymphocytes and subsets. In: Melo E, editor. XX World Congress of Pathological and Laboratory Medicine. Bologna: Litosei Rastignano; 1999. pp 95-100.